Report initial 30-day safety and biomarker data for the Imagine-1 study
Delivered after the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 11 Jan 2021
- Due
- 30 Jun 2021
- Delivered
- Q4 2021
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“is expected to report initial 30-day safety and biomarker data mid-year 2021.”
What we found
Evidence strength A What the grades mean
The company initially expected to report data by mid-year 2021, but later filings indicate the data was reported in the fourth quarter of 2021.
-
A Passage Bio, Inc. 10-Q filed 2021-08-05
“We expect to report initial safety and 30-day biomarker data from the initial cohort in the fourth quarter of 2021.” ✓ confirmed on the page
-
A Passage Bio, Inc. 10-K filed 2022-03-03
“In the fourth quarter of 2021, we reported initial safety and 30-day biomarker data from the initial cohort” ✓ confirmed on the page
Market reaction: the shares moved +2.7% against the S&P 500 over the three sessions around the disclosure (4 Aug 2021 to 9 Aug 2021). What this measures
Checked 24 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical readout
- Indicative materiality
- Medium rules
- Action
- Report
- Deliverable
- Initial 30-day safety and biomarker data
- Target
- 30 days
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- High
- Specificity
- High
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Passage Bio, Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-PASG-021450 · Corrections policy